Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.

Annual lung cancer screening, or LCS, detects cancer at a higher rate and at earlier stages, findings suggest.According to Roger Y. Kim, MD, MSCE, DAABIP, ATSF, an assistant professor of medicine at ...

with chemotherapy in stage 2 to 3b non-small cell lung cancer (NSCLC) patients who can be treated with surgery, followed by Keytruda and V940 given as adjuvant therapy. Specifically, it will enrol ...

Dr. Neelu Puri is leading lung cancer research at the University of Illinois College of Medicine Rockford, promoting early ...

Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo Oviedo-Mori survive — and thrive — with advanced lung cancer for 15 years.

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...

Screening adherence is associated with increased overall and early-stage lung cancer detection rates among individu ...

12, 2025 — Researchers have found that some particularly aggressive lung cancer cells ... Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage Cancer Patients in Phase 1 Trial ...

Since 2021, when lung cancer screening guidelines began to include younger people and those with a lower smoking history, the number of screenings climbed, but significant gaps remain, especially ...